The combination of p53 mutation and neu/erbB-2 amplification is associated with poor survival in node-negative breast cancer

S. B. Bull, H. Ozcelik, D. Pinnaduwage, M. E. Blackstein, T. C. Hurd

Research output: Contribution to journalComment/debate

Original languageEnglish (US)
Pages (from-to)276-277
Number of pages2
JournalBreast Diseases
Volume15
Issue number3
StatePublished - Dec 1 2004

ASJC Scopus subject areas

  • Surgery
  • Oncology

Cite this